These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32706072)

  • 21. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.
    Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E
    Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
    Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
    J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalein targets STMN1 to inhibit the progression of nasopharyngeal carcinoma via regulating the Wnt/β-catenin pathway.
    Li Z; Cai X
    Environ Toxicol; 2024 May; 39(5):3003-3013. PubMed ID: 38317500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer.
    Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
    Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1.
    Li S; Ji J; Zhang Z; Peng Q; Hao L; Guo Y; Zhou W; Cui Q; Shi X
    Mol Cell Biochem; 2020 Dec; 475(1-2):79-91. PubMed ID: 32761300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
    Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
    Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
    Liu FH; Cui YP; He YK; Shu RH
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
    Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
    Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro.
    Xu C; Liu C; Huang W; Tu S; Wan F
    Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):268-79. PubMed ID: 23419720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.
    Chen B; Pan Y; Xu X; Wu F; Zheng X; Chen SY; Zhao YT; Huang Z; Cheng SH; Liu JX; Wang WH; Li YX
    Biomed Pharmacother; 2020 Aug; 128():110284. PubMed ID: 32480224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.
    Min Q; Molina L; Li J; Adebayo Michael AO; Russell JO; Preziosi ME; Singh S; Poddar M; Matz-Soja M; Ranganathan S; Bell AW; Gebhardt R; Gaunitz F; Yu J; Tao J; Monga SP
    Am J Pathol; 2019 May; 189(5):1091-1104. PubMed ID: 30794807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YAP1-activated ZNF131 promotes hepatocellular carcinoma cell proliferation through transcriptional regulation of PAIP1.
    Yin G; Jia S; Zhang Y; Xian Y; Guo Y; Liu Q
    Arch Biochem Biophys; 2024 Apr; 754():109921. PubMed ID: 38341068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
    Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
    Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
    Wu J; Chai H; Li F; Ren Q; Gu Y
    Life Sci; 2020 Nov; 260():118406. PubMed ID: 32918976
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Imura S; Yamada S; Saito YU; Iwahashi S; Arakawa Y; Ikemoto T; Morine Y; Utsunomiya T; Shimada M
    Anticancer Res; 2017 Oct; 37(10):5877-5883. PubMed ID: 28982915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.